Institutional investors purchased a net $1.0 million shares of THRX during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 84.47% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRIDIAN ASSET MANAGEMENT LLC Bought 1.6 Million shares of Theravance Inc
INVESCO POWERSHARES CAPITAL MANA... Bought 799.2 Thousand shares of Theravance Inc
THE VANGUARD GROUP, INC. Bought 515.1 Thousand shares of Theravance Inc